Femasys (NASDAQ:FEMY) Stock Price Up 1.4% – Should You Buy?

Femasys Inc. (NASDAQ:FEMY)’s share price was up 1.4% during trading on Tuesday . The company traded as high as $0.5599 and last traded at $0.5234. Approximately 883,604 shares were traded during trading, a decline of 14% from the average daily volume of 1,027,730 shares. The stock had previously closed at $0.5160.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the company. Wall Street Zen downgraded Femasys from a “hold” rating to a “sell” rating in a research report on Saturday, December 20th. Laidlaw assumed coverage on Femasys in a research report on Thursday, November 20th. They issued a “buy” rating and a $6.50 price target on the stock. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Femasys in a research report on Thursday, January 22nd. Three analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $6.83.

Femasys Trading Up 1.4%

The company has a current ratio of 1.16, a quick ratio of 0.61 and a debt-to-equity ratio of 0.01. The firm has a market capitalization of $30.61 million, a P/E ratio of -0.73 and a beta of -2.54. The firm has a 50-day moving average of $0.72 and a two-hundred day moving average of $0.67.

Femasys (NASDAQ:FEMY) last released its quarterly earnings data on Friday, November 14th. The company reported ($0.10) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.12) by $0.02. The business had revenue of $0.73 million during the quarter, compared to analysts’ expectations of $1.35 million. Femasys had a negative net margin of 960.80% and a negative return on equity of 764.26%. On average, analysts anticipate that Femasys Inc. will post -0.86 EPS for the current year.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the company. Jane Street Group LLC bought a new position in Femasys in the 2nd quarter valued at approximately $82,000. Osaic Holdings Inc. bought a new stake in Femasys during the 2nd quarter worth approximately $45,000. Finally, Clear Creek Financial Management LLC increased its position in Femasys by 4.2% in the 2nd quarter. Clear Creek Financial Management LLC now owns 281,821 shares of the company’s stock valued at $272,000 after acquiring an additional 11,450 shares during the period. 65.27% of the stock is currently owned by institutional investors.

About Femasys

Femasys International, Inc is a medical device company focused on the research, development and commercialization of innovative technologies for interventional women’s health applications. The company’s core activities center on creating minimally invasive diagnostic and therapeutic products designed to address uterine cavity evaluation and treatment and to improve outcomes in gynecological care.

The company’s flagship product, the FemVue® hydrosonography system, is a single-use catheter-based device that enhances visualization of the uterine cavity through saline infusion sonography.